UK markets closed
  • FTSE 100

    7,134.06
    +45.88 (+0.65%)
     
  • FTSE 250

    22,734.13
    +125.37 (+0.55%)
     
  • AIM

    1,249.65
    +3.03 (+0.24%)
     
  • GBP/EUR

    1.1648
    +0.0009 (+0.07%)
     
  • GBP/USD

    1.4117
    -0.0060 (-0.42%)
     
  • BTC-GBP

    24,933.39
    -101.37 (-0.40%)
     
  • CMC Crypto 200

    924.19
    -17.62 (-1.87%)
     
  • S&P 500

    4,247.44
    +8.26 (+0.19%)
     
  • DOW

    34,479.60
    +13.36 (+0.04%)
     
  • CRUDE OIL

    70.78
    +0.49 (+0.70%)
     
  • GOLD FUTURES

    1,879.50
    -16.90 (-0.89%)
     
  • NIKKEI 225

    28,948.73
    -9.83 (-0.03%)
     
  • HANG SENG

    28,842.13
    +103.25 (+0.36%)
     
  • DAX

    15,693.27
    +122.05 (+0.78%)
     
  • CAC 40

    6,600.66
    +54.17 (+0.83%)
     

Outlook on the $455+ Billion Physical, Engineering and Life Sciences Global Market to 2030 - Identify Growth Segments for Investment

·9-min read

Dublin, May 28, 2021 (GLOBE NEWSWIRE) -- The "Physical, Engineering, and Life Sciences Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.

This report provides strategists, marketers and senior management with the critical information they need to assess the global physical, engineering, and life sciences market as it emerges from the COVID-19 shut down.

The global physical, engineering, and life sciences market is expected to grow from $455.83 billion in 2020 to $484.71 billion in 2021 at a compound annual growth rate (CAGR) of 6.3%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $709.76 billion in 2025 at a CAGR of 10%.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.

  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.

  • Create regional and country strategies on the basis of local data and analysis.

  • Identify growth segments for investment.

  • Outperform competitors using forecast data and the drivers and trends shaping the market.

  • Understand customers based on the latest market research findings.

  • Benchmark performance against key competitors.

  • Utilize the relationships between key data sets for superior strategizing.

  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the physical, engineering, and life sciences? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Physical, Engineering, and Life Sciences market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider physical, engineering, and life sciences market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.

  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.

  • Market segmentations break down market into sub markets.

  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.

  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

  • The physical, engineering, and life sciences market section of the report gives context. It compares the physical, engineering, and life sciences market with other segments of the physical, engineering, and life sciences market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, physical, engineering, and life sciences indicators comparison.

Major players in the physical, engineering, and life sciences market are IQVIA Holdings Inc, Battelle Memorial Institute, Syneos Health Inc, PRA Health Sciences Inc, Charles River Laboratories International Inc, PAREXEL International Corporation, Pharmaceutical Product Development LLC, Medpace Holdings Inc, Albany Molecular Research Inc, Hitachi High Technologies America Inc

Physical, Engineering, and Life Sciences establishments are engaged in conducting research and experimental development in physical, engineering, and life sciences such as agriculture, environmental, botany, electronics, chemistry, fisheries, forests, mathematics, veterinary and other allied subjects. Research and development activities of physical engineering and life sciences organizations are funded by public sector organizations and commercial establishments. These organizations monetize their research findings, patents or products to fund their research activities

A major transformation is under progress in the life science industry. Much of it is driven by the digital transformation which has a powerful re-imagination of the life science industry. Technology firms such as Microsoft, Cisco, IBM, Amazon and Google serve as the driving forces and initiators of digital life sciences transformation. Mobile computing is poised to support the digitization of health in combination with drug therapy, as well as through stand-alone therapies. Digital transformation can help people more effectively for making decisions on how to run the existing business and position the organization for the future. This rise in digital transformation drive the market growth.

COVID-19 is unprecedented challenge to the global life sciences industry. Pharmaceutical and biotech companies around the globe are working with Governments to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. The UK and EU regulators have worked to provide up-to-date guidance in response to the evolving crisis, as well as to support research and development (R&D) that they hope will contain the impact of the spread. The MHRA stated that the safety of trial participants should be the first priority and this will remain its objective. These regulatory challenges can restrain the market growth.

The physical, engineering, and life sciences market is segmented by type into physical and engineering sciences, life sciences services and by entities into organizations, sole traders, partnerships.

The introduction and advancement of new technologies such as nano sensors, bi-specific antibodies and computational biology have illustrated the progress that can be achieved through collaboration across a variety of disciplines between researchers and organisations. Collaboration between industry and regulators will promote greater self-regulation rooted in a culture of quality, operational competence and monitoring of results. The FDA has also suggested that it plans to partner with businesses more collaboratively to get products to market faster. collaboration will allow stakeholders to provide more responsive, more cost-effective treatment and better results.

On Jan. 2020, Vaccitech have announced their strategic collaboration with the Ludwig Institute for Cancer Research and Cancer Research UK (CRUK). In this partnership, CRUK's Centre for Drug Development (CDD) will sponsor and manage a Phase I/II a clinical trial of the drug in combination with the current standard of care and first-line treatment (chemotherapy and anti-PD-1) in approximately 80 patients with the disease. The collaborators indicated new treatments for NSCLC are urgently needed, as it accounts for 88 percent of all cancer diagnoses in the UK each year, and only five percent of those survive for 10 years or more.

Key Topics Covered:

1. Executive Summary

2. Physical, Engineering, and Life Sciences Market Characteristics

3. Physical, Engineering, and Life Sciences Market Trends and Strategies

4. Impact of COVID-19 on Physical, Engineering, and Life Sciences

5. Physical, Engineering, and Life Sciences Market Size and Growth
5.1. Global Physical, Engineering, and Life Sciences Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on the Market
5.2. Global Physical, Engineering, and Life Sciences Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market

6. Physical, Engineering, and Life Sciences Market Segmentation

7. Physical, Engineering, and Life Sciences Market Regional and Country Analysis
7.1. Global Physical, Engineering, and Life Sciences Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Physical, Engineering, and Life Sciences Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Physical, Engineering, and Life Sciences Market

9. China Physical, Engineering, and Life Sciences Market

10. India Physical, Engineering, and Life Sciences Market

11. Japan Physical, Engineering, and Life Sciences Market

12. Australia Physical, Engineering, and Life Sciences Market

13. Indonesia Physical, Engineering, and Life Sciences Market

14. South Korea Physical, Engineering, and Life Sciences Market

15. Western Europe Physical, Engineering, and Life Sciences Market

16. UK Physical, Engineering, and Life Sciences Market

17. Germany Physical, Engineering, and Life Sciences Market

18. France Physical, Engineering, and Life Sciences Market

19. Eastern Europe Physical, Engineering, and Life Sciences Market

20. Russia Physical, Engineering, and Life Sciences Market

21. North America Physical, Engineering, and Life Sciences Market

22. USA Physical, Engineering, and Life Sciences Market

23. South America Physical, Engineering, and Life Sciences Market

24. Brazil Physical, Engineering, and Life Sciences Market

25. Middle East Physical, Engineering, and Life Sciences Market

26. Africa Physical, Engineering, and Life Sciences Market

27. Physical, Engineering, and Life Sciences Market Competitive Landscape and Company Profiles
27.1. Physical, Engineering, and Life Sciences Market Competitive Landscape
27.2. Physical, Engineering, and Life Sciences Market Company Profiles
27.2.1. IQVIA Holdings Inc
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Battelle Memorial Institute
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Syneos Health Inc
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. PRA Health Sciences Inc
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Charles River Laboratories International Inc
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

29. Key Mergers and Acquisitions in the Physical, Engineering, and Life Sciences Market

29. Physical, Engineering, and Life Sciences Market Future Outlook and Potential Analysis

30. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/rifdo

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900